Wegovy has gained attention as a powerful weight loss medication, especially for those struggling with obesity. However, if ...

Medicare must recognize obesity as a chronic disease and provide coverage for the treatments that can help those who struggle ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.

Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...

Supplies of high-demand obesity drugs are improving – but they’re not easier to get - ‘There are a lot of people right now ...

It’s time to treat obesity as a chronic disease and have Medicare cover these life-changing AOMs. By taking action now, we ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

Medicare, the government-backed program for ... Ozempic, which has also been used off-label for obesity, saw a more than 16-fold rise in spending to $9.2 billion in 2023 from 2019 - roughly ...

Supporters are encouraged to sign the "Commit to Care" Pledge at ObesityCareWeek.org, promoting awareness, advocacy and respect for individuals affected by obesity. Advocates are also urged to support ...